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KESAN MADU TUALANG TERHADAP TINDAK BALAS NOSISEPTIF 
DALAM TALAMUS PADA ANAK TIKUS JANTAN YANG TELAH 
DIDEDAHKAN TEKANAN SEMASA DALAM PRANATAL 
ABSTRAK 
 
Pelbagai rumusan mekanisme perubahan tindak balas terhadap nosiseptif 
anak yang terdedah kepada tekanan pranatal; namun tidak ada satu kajian yang 
menyelidiki peranan talamus dalam modulasi nosiseptif. Tujuan pertama kajian ini 
adalah untuk mengkaji kesan tekanan pranatal terhadap tingkah laku nosiseptif, 
perubahan morfologi, paras parameter tekanan oksidatif dan reseptor NMDA dalam 
talamus pada anak tikus jantan yang telah diberi tekanan semasa dalam pranatal. 
Tujuan kedua adalah untuk menentukan kesan madu Tualang terhadap parameter 
yang dikaji. Tiga puluh tiga ekor tikus Sprague Dawley yang bunting telah 
dimasukkan secara rambang ke dalam kumpulan kawalan, tekanan dan tekanan yang 
dirawat dengan madu Tualang. Madu Tualang (1.2g / kg berat badan / hari) atau air 
suling telah diberikan secara oral kepada tikus bunting pada kumpulan yang sepadan. 
Tekanan kekangan telah diberikan kepada kumpulan tekanan dan kumpulan yang 
dirawat dari hari ke 11 kebuntingan hingga melahirkan anak. Najis ibu telah 
dikumpulkan (pada hari ke 11 dan 21) untuk mengukur paras kortikosteron. Selepas 
kelahiran, anak tikus dewasa didedahkan kepada ujian tingkah laku nosiseptif (n = 7 
setiap kumpulan). Dalam ujian formalin, skor tingkah laku nosiseptif mereka telah 
dicatatkan. Tikus telah dikorbankan dua jam selepas suntikan formalin. Selepas itu, 
talamus anak tikus jantan dikeluarkan untuk menentukan paras parameter tekanan 
oksidatif dan reseptor NMDA manakala pewarnaan Nissl dilakukan untuk mengesan 
perubahan morfologi dalam talamus. Semua data dianalisis dengan menggunakan 
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SPSS, versi 22. Skor tingkah laku nosiseptif dianalisis dengan menggunakan analisis 
varians pengiraan berulang (ANOVA) dengan pembetulan Bonferroni dan data yang 
selebihnya dianalisis dengan menggunakan ANOVA satu hala. Hasil kajian ini 
menunjukkan penurunan yang ketara dalam skor tingkah laku nosiseptif (P <0.05), 
paras malondialdehida yang rendah dengan paras katalase (P <0.05), superoxida 
dismutase (P <0.05) dan glutation (P <0.001) yang lebih tinggi dalam kumpulan 
tekanan yang dirawat dengan madu Tualang berbanding dengan kumpulan tekanan. 
Pemerhatian histologi menunjukkan pengurangan neuron Nissl positif yang jelas (P 
<0.05) dalam nukleus ventral posteralateral talamus di bahagian sebelah kiri pada 
kumpulan tekanan berbanding kumpulan lain. Daripada kajian ini, ia dapat 
disimpulkan bahawa tekanan prenatal menyebabkan perubahan pada tingkah laku 
nosiseptif, parameter tekanan oksidatif, morfologi dan paras reseptor NMDA dalam 
talamus anak tikus jantan. Selain itu, pemberian madu Tualang semasa tekanan 
pranatal dikaitkan dengan penambahbaikan dalam tingkah laku nosiseptif, parameter 
tekanan oksidatif, dan morfologi dalam talamus anak tikus jantan. Walau 
bagaimanapun, pemberian madu Tualang tidak menyebabkan penurunan yang ketara 
pada paras reseptor NMDA. Kajian ini memberikan pengetahuan baru mengenai 
kemungkinan mekanisme antioksidan madu Tualang dalam mengubah tindak balas 
nosiseptif dalam talamus anak tikus jantan yang telah diberi tekanan semasa dalam 
pranatal. 
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THE EFFECTS OF TUALANG HONEY ON NOCICEPTIVE RESPONSES IN 
THE THALAMUS OF PRENATALLY STRESSED MALE RATS 
OFFSPRING 
ABSTRACT 
 
Various mechanisms have been postulated to contribute to alteration of 
nociceptive responses in offspring exposed to prenatal stress; however not a single 
study has investigated the possible role of thalamus in the nociceptive modulation. 
The first aim of this study was to investigate the effects of prenatal stress on 
nociceptive behaviour, morphological changes, level of oxidative stress parameters 
and NMDA receptors in the thalamus of prenatally stressed male rats offspring. The 
second aim was to determine the effects of Tualang honey on these parameters. 
Thirty-three Sprague Dawley pregnant rats were randomised into control, stress and 
stress-treated with Tualang honey groups. Oral administration of Tualang honey 
(1.2g/kg body weight/day) or distilled water was given to the corresponding pregnant 
dams. Restraint stress was applied to the stress and stress-treated groups from day 11 
of pregnancy until delivery. Maternal faeces were collected (on day 11 and 21) to 
measure the level of corticosterone. After parturition, male rats offspring were 
subjected for nociceptive behavioural testing (n=7 per group). In formalin test, their 
nociceptive behavior score was recorded. The rats were sacrificed two hours post 
formalin injection. After that, thalamus of the male rats offspring was removed to 
determine the level of oxidative stress parameters and NMDA receptors while Nissl 
staining was performed to detect the morphological changes in the thalamus. All data 
were analysed by using SPSS, version 22. Nociceptive behaviour score was analysed 
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by using repeated measures analysis of variance (ANOVA) with Bonferroni 
correction and the remaining data were analysed by using one-way ANOVA. The 
results of this study demonstrated a significant decrease in nociceptive behaviour 
score (P<0.05), lower malondialdehyde level with higher catalase, superoxide 
dismutase activities (P<0.05) and glutathione (P<0.001) in stress-treated with 
Tualang honey group compared to stress group. Histological observations 
demonstrated a significant (P<0.05) reduction of Nissl-positive neurons in the left 
ventral posterolateral thalamic nuclei of the stress group compared to other groups. 
From this study, it can be concluded that prenatal stress was associated with 
alteration in nociceptive behavior, oxidative stress parameters, morphology and level 
of NMDA receptors in the thalamus of adult rats offspring. In addition, Tualang 
honey administration was associated with improvement in nociceptive behaviour, 
oxidative stress parameters and morphology in the thalamus of male rats offspring. 
However, Tualang honey administration did not significantly reduce the NMDA 
receptors level. The present study provides new knowledge regarding possible 
mechanisms of antioxidant property of Tualang honey in modulating the nociceptive 
responses in the thalamus of prenatally stressed male rats offspring. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Background of study 
It is estimated that up to 20% of pregnant women experience anxiety and depression 
(Barlow et al., 2014). Exposure to physiological stress during pregnancy has been 
associated with pregnancy complications and disorder in offspring’s cognitive, 
behaviour and physical development. Variations in prenatal environment and 
condition can affect the responses of the offspring. Earlier studies demonstrated that 
prenatal stress has been associated with development of abnormal behaviour in later 
life of the offspring such as attention deficit hyperactivity disorder (ADHD) 
(Rodriguez and Bohlin, 2005), schizophrenia (Dong et al., 2015) and depression 
(Kingsbury et al., 2016). Previous reports have demonstrated that prenatal stress was 
associated with alteration in the nociceptive responses of the offspring (Sandercock 
et al., 2011; Abd Aziz et al., 2013) and a report has suggested that stressful prenatal 
period was associated with modulation of nociceptive-neuronal network in the 
offspring which led to pain hypersensitivity (Chen et al., 2010). 
1.1.1 The effects of prenatal stress on brain 
Stress during the pregnancy can have long term impacts on offspring development 
due to the critical periods in the development of brain circuity associated with early 
growth (Weinstock, 2005). Stress during pregnancy can also lead to increase 
glucocorticoid in the blood of the dams and the foetus, and may contribute to 
increased oxidant level and alterations of the structure and function of the developing 
brain (Mennes et al., 2009; Buss et al., 2010; Sahu et al., 2012). 
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Previous study has shown that prenatal stress was associated with decreased 
numerical density of neurons and altered neurotransmitter systems in the 
hippocampus (Dyuzhikova et al., 2012). The alteration might be due to vulnerability 
of the brain to oxidative injury as it has modest antioxidant defences (Halliwell, 
2006). As a result, the brain produces a large amount of free radical by-products, 
consequently lead to an imbalance between production and secretion of free radicals 
and antioxidants that result in oxidative stress (Ha et al., 1998). A significant 
decrease in number of neurons and an increment in production of reactive oxygen 
species as well as expression of neuronal nitric oxide synthase were found in 
prenatally stressed rat hippocampus (Zhu et al., 2004). The study demonstrates that 
prenatal stress is associated with oxidative stress and neurons injury which leads to 
neuronal loss in the brain of offspring (Zhu et al., 2004). 
1.1.2 Thalamus and pain 
Previous findings have shown the effects of prenatal stress on cerebral cortex (Charil 
et al., 2010), cerebellum (Maur et al., 2012), hippocampus (Walf and Frye, 2012) 
and amygdala (Zohar and Weinstock, 2011) but no report has yet been done in the 
thalamus. Thalamus is regarded as an entrance to the cerebral cortex. Almost all 
somatosensory inputs converge on to the thalamus including the nociceptive inputs. 
The thalamus is a crucial relay station for transmitting nociceptive information to the 
cerebral cortex. Somatic sensation such as nociception or reactivity to tissue 
damaging stimuli is conveyed via nociceptors to the spinal cord, which later 
transferred by ascending tracts to the thalamus and cerebral cortex, where pain is 
recognised. In 1911, Head and Holmes proposed the thalamus as the important organ 
of the affective side of our sensation, especially pain. The thalamus is a key to pain 
sensation and induced pain in chronic pain conditions. A few studies indicated the 
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involvement of both the lateral and medial thalamus in pain processing as bilateral 
lesion of one of these areas would change pain behaviours (Saadé et al., 1999; Wang 
et al., 2007). 
Pain receptors or nociceptors will be stimulated by noxious stimuli. During 
inflammation, cells are damaged and several chemicals are released including 
histamine, bradykinin, serotonin, potassium and prostaglandins which may sensitise 
nociceptors and produce hyperalgesia and allodynia. Prolonged discharge of 
nociceptors (C-fibres) results in release of glutamate which acts on N-methyl-D-
aspartate (NMDA) receptors. Activation of NMDA receptors results in increased cell 
response to pain stimuli resulting in central sensitisation. There is growing evidence 
to show that NMDA receptors are associated with generation and maintenance of 
central sensitisation during pain conditions. NMDA receptors also mediate peripheral 
sensitisation and visceral pain. 
Moreover, thalamic NMDA receptors contribute to the development and 
maintenance of hyperalgesia in the inflammatory pain model (Kolhekar et al., 1997). 
Study conducted by Reyes et al. (2012) demonstrated that the activation of neuronal 
NMDA receptors induced the release of superoxide mediated oxidative stress in 
neighbouring neuron and astrocytes. The mechanism for the increase in oxidative 
stress markers is might be due to calcium dysregulation as a result of NMDA 
receptors hyperactivity which lead to neurotoxicity (Brittain et al., 2012). However, 
the exact mechanisms of NMDA receptors in the thalamus offspring exposed to 
prenatal stress leading to alteration of nociceptive behaviour in the offspring are not 
yet clearly understood. Available evidence shows that prenatal stress are more 
susceptible to oxidative stress due to higher levels of oxidants or lower antioxidants. 
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Therefore, it has been postulated that antioxidant supplementation in such individuals 
may be beneficial. 
1.1.3 Therapeutic potential of Tualang honey 
A type of rainforest honey known as Tualang honey contains the strongest 
antioxidant and act as a free radical scavenger. It had variety kinds of 
phytochemicals which serves as sources of dietary and potential health benefits. 
Tualang honey can be used as an alternative treatment because of its antioxidant 
property. Prior studies also found that co-administration of Tualang honey with other 
therapeutic agents may be effective in minimising the side effects of synthetic drugs 
(Erejuwa et al., 2012). 
Generally, Tualang honey is a natural product consisting of variable compositions. 
These variances based on floral sources, geographical origin, total phenolic content, 
water proportion and colour (Frankel et al., 1998; Mohamed et al., 2010). 
Previously, it has been extensively studied in the treatment of various medical 
conditions and has been found to have therapeutic activities including antibacterial 
(Nasir et al., 2010), anti-inflammatory (Bashkaran et al., 2011), antiproliferative 
(Ghashm et al., 2010), anticancer (Fauzi et al., 2011), antidiabetic and antioxidant 
properties (Erejuwa et al., 2010). 
Tualang honey was chosen in this study as the previous studies demonstrated that 
Tualang honey seems to be more effective than other honey because it contains 
higher flavonoids and phenolic content (Khalil et al., 2011; Kishore et al., 2011). It 
contains phenolic compounds with good colour intensity which has good antioxidant 
activity (Mohamed et al., 2010). Antioxidant protective effect of Tualang honey able 
to modulate anxiety-like behaviour (Al-Rahbi et al., 2014c), improves brain 
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morphology (Othman et al., 2015) and reduce brain oxidative stress (Erejuwa et al., 
2010). The antioxidant property of Tualang honey would be beneficial to prevent 
alteration of the brain structure and function that might contribute to development of 
pathological pain following prenatal stress. 
1.2 Justification of the study 
Although, several studies have demonstrated that prenatal stress is associated with 
development of oxidative stress and activation of NMDA receptors in the central 
nervous system, the exact mechanisms of maternal stress leading to alteration of 
nociceptive responses in the offspring are not yet clearly understood. Whether 
prenatal stress may affect the level of oxidative stress markers, morphology and 
NMDA receptors in the thalamus need to be investigated. In addition, it is not known 
whether there are protective effects of Tualang honey administration during prenatal 
stress on the alteration in the level of oxidative stress markers, morphology and 
NMDA receptors in the thalamus of male rat offspring. 
1.3 Research objectives 
1.3.1 General objectives 
To investigate the effects of prenatal stress on nociceptive behaviour, level of 
oxidative stress parameters, morphological changes and NMDA receptors in the 
thalamus of prenatally stressed male rats offspring and to determine the protective 
effects of Tualang honey administration during prenatal stress on these parameters. 
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1.3.2 Specific Objectives 
1. To determine the effects of prenatal stress on nociceptive behaviour, 
oxidative stress parameters, morphology and level of NMDA receptors in 
the thalamus of male rats offspring. 
2. To determine the effects of Tualang honey administration to the pregnant 
dams on nociceptive behaviour of prenatally stressed male rats offspring. 
3. To determine the effects of Tualang honey administration to the pregnant 
dams on oxidative stress parameters in the thalamus of prenatally stressed 
male rats offspring. 
4. To determine the effects of Tualang honey administration to the pregnant 
dams on thalamus morphology of prenatally stressed male rats offspring. 
5. To determine the effects of Tualang honey administration to the pregnant 
dams on the level of NMDA receptors in the thalamus of prenatally 
stressed male rats offspring. 
1.4 Hypothesis of the study 
1. There are significant changes in nociceptive behaviour, oxidative stress 
parameters, morphology and level of NMDA receptors in the thalamus of 
prenatally stressed male rats offspring. 
2. There is a significant change in nociceptive behaviour of the prenatally 
stressed male rats offspring following Tualang honey administration to the 
pregnant dams. 
3. There is a significant change in the level of oxidative stress parameters of 
prenatally stressed male rats offspring following Tualang honey 
administration to the pregnant dams. 
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4. There is a significant change in thalamus morphology of prenatally stressed 
male rats offspring following Tualang honey administration to the pregnant 
dams. 
5. There is a significant change in the level of NMDA receptors of prenatally 
stressed male rats offspring following Tualang honey administration to the 
pregnant dams. 
1.5 Research questions 
1. Are there any changes in nociceptive behaviour, oxidative stress parameters, 
morphology and level of NMDA receptors in the thalamus of prenatally 
stressed male rats offspring? 
2. Is there any change in nociceptive behaviour of the prenatally stressed male 
rats offspring following Tualang honey administration to the pregnant dams? 
3. Is there any change in the level of oxidative stress parameters of prenatally 
stressed male rats offspring following Tualang honey administration to the 
pregnant dams? 
4. Is there any change in thalamus morphology of prenatally stressed male rats 
offspring following Tualang honey administration to the pregnant dams? 
5. Is there any change in the level of NMDA receptors of prenatally stressed 
male rats offspring following Tualang honey administration to the pregnant 
dams? 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Pregnancy 
Pregnancy occurs when a fertilised egg (zygote) is implanted in a woman’s uterus 
(Jones, 2010). The length of gestation averages 266 days to 280 days, or 38 to 40 
weeks after ovulation (Yates, 2010). Meanwhile, in rats, the duration of pregnancy is 
about 21 to 22 days (Amugongo and Hlusko, 2014). Pregnancy is an experience that 
changes various prospect and has important consequences for healthy life and social 
roles in women (Striegel-Moore et al., 1996; Yali and Lobel, 2002). 
2.1.1 Physiological changes during pregnancy 
During pregnancy, the pregnant mother undergoes a lot of physiological and 
homeostatic mechanisms which are necessary to ensure proper foetal development. 
These changes begin after conception and affect every system in the body (Lockitch, 
1997). Early changes during pregnancy occur due to increased metabolic needs 
secondary to development and growth of foetus, uterus and placenta, and high level 
of hormones especially oestrogen and progesterone. The physiological changes 
include the changes in cardiovascular and systemic circulation, reproductive organ, 
urinary tract, respiratory tract and endocrine system (Campbell and Lees, 2000). 
However, starting from mid pregnancy onwards, the changes are partly contributed 
by mechanical pressure from the growing uterus (Ciliberto and Marx, 1998). 
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2.1.2 Endocrinological changes of pregnancy 
During pregnancy, there are a lot of physiological changes that involves the 
endocrine system of the mother and her foetus (Kumar and Magon, 2012). The 
endocrine regulation of human foetal growth involves interaction between the foetus, 
placenta and mother (Murphy et al., 2006). Steroid hormone released by the 
endocrine system is important to regulate physiological events that are essential for 
maintaining pregnancy and foetal development (Pepe and Albrecht, 1995). 
All steroid hormones are derived from cholesterol. They are secreted by adrenal 
cortex, ovary and placenta during pregnancy. The adrenal glands secrete a lot of 
steroid hormones such as mineralocorticoid for sodium regulation and also 
androgens for regulation of sexual function and reproduction (Venning, 1946). 
Meanwhile, the ovaries produce the hormones necessary for the growth and 
development of primary and secondary reproductive organs and structures, whereas, 
the placenta plays an important role in synthesising and secreting peptides and 
steroid hormones that regulate hormonogenesis by the endocrine glands in the 
mother and the foetus (Tal et al., 2000). 
The release of hormones is largely controlled by the foetal-placental unit (FPU). 
Many endocrine and metabolic changes that occur during pregnancy can be directly 
associated to hormonal signals originating from the FPU (Tal et al., 2000). The 
uterus in pregnant woman is a home for the growing foetus and any type of stress on 
the mother may contribute to adverse effect on pregnancy outcomes (Mulder et al., 
2002) or have a long-term effect on brain and behaviour disorders in offspring 
(Weinstock, 2008). 
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In pregnancy, the level of cortisol (stress hormone) is higher than non-pregnant level 
by the third trimester (Jung et al., 2011) due to oestrogen stimulation of 
corticosteroid-binding globulin synthesis (Demey-Ponsart et al., 1982; Qureshi et al., 
2007). Moreover, the placenta releases a high number of corticotrophin-releasing 
hormones (CRH) into the mother’s bloodstream during the last trimesters of 
pregnancy (Hillhouse et al., 1993; Petraglia et al., 1993; Reis et al., 1999). During 
stress, regulation of the maternal hypothalamic-pituitary-adrenal (HPA) axis 
undergoes significant changes as described in section 2.2.1 (a). 
2.2 Stress 
Stress can be described as negative “emotional experience accompanied by 
predictable biochemical, physiological and behavioural changes”. Stress also refers 
to situations that tend to disturb the stability between living organisms and their 
surroundings. In daily life there are various stressful situations such as work 
pressure, emotional and psychosocial stress, as well as physical stress due to trauma, 
surgery and numerous medical disorders (Baum, 1990). In animal studies, there are 
various models of stress that can be used to investigate pathophysiology of acute 
stress disorders, depression and anxiety. 
Chronic stress is an individual response to emotional stress experienced over a long 
period of time. Several studies suggest that chronic stress has shown a relationship 
between life events and psychological adjustment (Latendresse, 2009). It was also 
reported that chronic stress was associated with increased incidence of preterm 
delivery (Latendresse, 2009). 
In contrary to chronic, acute stress refers to sudden stressful changes in an 
individual’s situation or conditions. In animal studies, acute stress may be acquired 
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by releasing sudden loud noise or by keeping the animals in a situation that is 
restricted for a certain period. The study conducted by Sobrian et al. (1997) 
demonstrated that the exposure of pregnant animals to physiological stimulation 
caused by the noise results in alterations of development and immune system in the 
offspring.  
2.2.1 Prenatal stress 
Prenatal stress refers to the stress experienced by a mother during her pregnancy, 
usually due to stressful life events or environmental difficulties (Mulder et al., 2002; 
Markham and Koenig, 2011). Prenatal stress can be chronic, associated with ongoing 
events in a woman’s life, or acute, related to sudden changes in a women’s daily 
routine or environment.  
2.2.1 (a) Endocrinological changes during prenatal stress 
The pregnant women who are exposed to stress may develop numerous endocrine 
changes, including increased catecholamine and activation of HPA axis. During 
stress, catecholamine such as epinephrine and norepinephrine will be released by the 
sympathetic-adrenal medullary system into the blood. These hormones are important 
in a “fight or flight” response, facilitating several physiological changes such as 
increased in heart rate, blood pressure, mental activity, mobilization of energy stores 
and cellular metabolism and a decrease in blood flow to organs that are not needed 
for rapid activity (Guyton, 1981).  
Meanwhile, the activation of maternal HPA axis will stimulate glucocorticoid 
secretion. The placenta forms a structural and biochemical barrier to many of these 
maternal factors, although some will still enter the foetal circulation. There may also 
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be indirect effects on the foetus through modification of placental function. As an 
example, maternal glucocorticoid may stimulate the production of CRH by the 
placenta which in turn will activate the foetal HPA axis (Challis et al., 2000). 
Glucocorticoid will further stimulate the placenta to release more CRH. Placental 
CRH, on the other hand, will stimulate the pituitary and adrenal glands that lead to 
higher level of glucocorticoid in the maternal blood (Figure 2.1). 
The foetus is partially protected from a high maternal glucocorticoids (stress 
hormones) level by the action of the placental enzyme 11-β-hydroxysteroid 
dehydrogenase type-2 (11βHSD2) (Duthie and Reynolds, 2013). This enzyme 
protects the foetus from excessive exposure to glucocorticoid by catalysing the 
conversion of cortisol to cortisone (Murphy et al., 1974; Bernal et al., 1980; 
Benediktsson et al., 1997). 
Almost 80-90% of cortisol is metabolised by the placenta during gestation, but, high 
cortisol level can still reach the foetus (Gitau et al., 2004) and the ‘boundary’ may be 
weakened following stressful events e.g. maternal anxiety (Glover et al., 2009; 
Ponder et al., 2011), infection (Johnstone et al., 2005) and inflammation 
(Kossintseva et al., 2006) enabling more cortisol transfer from mother to foetus. 
Exposure to high levels of cortisol may affect the development of foetal structure 
and therefore influence the physical, cognitive of behavioural effect in the adult 
offspring (Groothuis et al., 2005; Kapoor et al., 2006).   
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Figure 2.1 HPA axis in pregnancy. During pregnancy, maternal pituitary and 
adrenal is stimulated by placental CRH, which leads to an increase cortisol 
production. High cortisol level can stimulate the production of placental CRH. 
Passage of cortisol across the placenta is partially inhibited by placental 11βHSD2. 
The enzyme will convert cortisol to inactive metabolite (cortisone). Excessive 
exposure of glucocorticoid has adverse outcome to the growing foetus. [Modified 
from Duthie and Reynolds (2013)]. HPA: hypothalamic-pituitary-adrenal axis, CRH: 
corticotrophin-releasing hormone, ACTH: Adrenocorticotropic hormone, 11βHSD2: 
11-β-hydroxysteroid dehydrogenase type-2. 
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2.2.2 Animal stress model 
To assess the effects of prenatal stress on the offspring, various animal models have 
been used. The type of stress used depends on the objectives and parameters of the 
research. Several types of stressors are widely used which include neonatal isolation 
stress, noise-induced stress, low temperature-induced stress and physical restraint 
stress. 
2.2.2 (a) Neonatal isolation stress 
Neonatal isolation or maternal separation is an early-life stressful event that 
contributes to long-term effects on neural and behavioural development in the adult 
offspring (Francis and Meaney, 1999). During the neonatal isolation procedure, a 
new born offspring is removed from the cage after birth and is put in another cage for 
one hour in a room located separately from the animal facility. The white sound is 
played in the background to cover the sounds of other pups. After 1 hour, the litter is 
placed back in the cages with their dams (Kosten et al., 2000; Kosten and Ambrosio, 
2002). Separation procedure is performed once a day for 8 days. This model has been 
widely used to demonstrate the effect of early lifetime stress on anxiety like 
behaviours in the offspring (Kosten and Kehoe, 2005; Lai et al., 2008; Maniam and 
Morris, 2010; Babygirija et al., 2012). 
2.2.2 (b) Noise-induced stress 
Human are often exposed to noise that may be harmful in the daily life. In laboratory 
animals, noise stress can be induced by using loudspeakers (15 W) connected to a 
noise generator (0-26 kHz) placed 30 cm above the cage. Animals can be exposed to 
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the noise protocol either acutely or repeatedly depends on the level of noise (4 
hours/day/15 days) (Manikandan and Devi, 2005; Ravindran et al., 2005).  
2.2.2 (c) Low temperature-induced stress 
Changes in body temperature result in stressful responses because of the activation of 
the thermoregulatory centre and HPA axis (Kvetnansky et al., 1971). The sudden 
reduction in temperature by using cold water such as immersed the animals in cold 
water (15-18 °C for 15-30 min) or place the animals (in their home cages) in cold or 
isolated environment (4 °C for 15-30 min) is frequently used to induce low 
temperature stress in animals experiment. 
2.2.2 (d) Restraint and immobilisation stress 
Restraint and immobilisation stress protocols are widely used to induce stress related 
behaviour, biochemistry and physiological changes in animals models (Kvetnansky 
and Mikulaj, 1970). Basically, the restraint stress is induced by placing the animal in 
a cylindrical or semi-cylindrical tube with ventilation holes for 120-180 min 
(Padovan and Guimaraes, 2000; Campos et al., 2010). Meanwhile, in the 
immobilisation stress protocols, animals are restrained by gentle wrapping of their 
upper and lower limbs with adhesive tape for 120 min (Hill et al., 2009; Shansky et 
al., 2009). The head movements are constrained by wound metal loops around the 
neck. This procedure can be used to induce acute or chronic stress (7-21 days). The 
immobilisation model produces inevitable physical and mental stress with a low rate 
of adaptation (Kasuga et al., 1999). After the restraint or immobilisation stress, the 
animal reveals an increase in anxiety level in the elevated plus maze test and other 
tests of anxiety (Padovan and Guimaraes, 2000; Campos et al., 2010). Some reports 
using restraint models indicate that this type of stress is sufficient to influence the 
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reproductive outcome in pregnant rats (Haron et al., 2014) and altered nociceptive 
responses in the offspring (Abd Aziz et al., 2013). 
2.3 Effect of prenatal stress on the foetus 
Apparently, the environmental effects on foetal development can influence the 
cognitive, behavioural and development of the offspring. Previous studies have 
shown that maternal exposure to stressful situations during pregnancy can have long-
term effects on the neurodevelopment of the offspring. 
2.3.1 Effect on cognition 
Acute prenatal stress has been shown to influence the cognition of children, or the 
ability to think. A study was conducted to determine the children’s cognitive abilities 
by monitoring pregnant women and their children after a severe ice storm (King and 
Laplante, 2005). The children reveal low cognitive and linguistic capabilities when 
exposed to high levels of objective prenatal stress compared to the children exposed 
to low levels. Another study showed correlation of prenatal stress with performance 
of the infant at three and eight months of age. Their findings revealed that mothers 
with high cortisol levels during mid-pregnancy had children with lower in cognitive 
tests compared to their peers. This effect was more obvious for the older children 
compared to the younger age group (Buitelaar et al., 2003). 
2.3.2 Effect on behaviour 
Reports have shown that prenatal stress affects the behaviour of children (Aloisi et 
al., 1998; Weinstock, 2001; Weinstock, 2007; Rutherford et al., 2009). Children 
exposed to prenatal stress may have emotional problems such as abnormal attitudes 
and difficult to pay attention. A study was carried out on monkeys and demonstrated 
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that psychological disturbance during pregnancy affected the offspring behaviour 
(Clarke and Schneider, 1993). The offspring showed more abnormal social behaviour 
compared to control (Clarke and Schneider, 1993). Another study suggests that 
prenatal stress can affect the ability to deal with stress and can lead to behavioural 
disorders in conflict-inducing situations in young and adult offspring (Braastad, 
1998). Previous study conducted by Takahashi et al. (1992) had demonstrated that 
prenatal stress results in increased behavioural response to stress in early life and 
continues into adulthood. 
2.3.3 Effect on nociceptive response 
The stressful prenatal events can significantly affect the development of central 
nervous system including the nociceptive neuronal network and this may influence 
the pain responses in later life of the offspring (Fitzgerald, 2005). Published data 
indicated an alteration of pain sensitivity to acute nociceptive stimulation in offspring 
exposed to prenatal stress (Kinsley et al., 1988; Smythe et al., 1994; Sternberg, 
1999). Besides that, the nociceptive response modulation associated with prenatal 
stress has been observed in early postnatal ontogenesis and in adulthood. Following 
prenatal stress the pain sensitivity can be altered due to changes in the hormones and 
neuronal network in the developing brain of the offspring (Peters, 1982; Peters, 
1988; Reznikov et al., 2001). 
There is convincing evidence that prenatal stress modulates the nociceptive 
sensitivity in the offspring by affecting the duration of tonic pain (Butkevich, 2002). 
This study suggests that prenatal stress stimulation used during critical periods of 
ontogeny (Kassil’ et al., 2000) may affect the sensitivity of the pain not only 
temporary, but also long-lasting pain stimulation (Smythe et al., 1994). Previously, 
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prenatal stress has been linked to increased nociceptive response in the new-borns by 
demonstrating that exposure to prenatal stress elevated the perception of the new-
borns to painful heel prick (Davis et al., 2011). 
In contrast to findings in neonatal prenatally stressed rats, a study that assessed 
nociception after weaning (week 8-10) found that prenatal stress was associated with 
increased nociceptive response to noxious stimuli or formalin injection, which 
showed increased sensitivity to the pain in adult offspring (Abd Aziz et al., 2013). 
Apparently, the results show that there is a marked long-term effect of prenatal stress 
on nociceptive responses in the offspring. However, the exact mechanism for the 
alteration of nociceptive responses is not really known and further studies need to be 
investigated. 
2.4 Pain 
2.4.1 Definition of pain 
In 1994, the International Association for the Study of Pain (IASP) defined pain as 
“an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or describe in terms of such damage”. In medical situation, pain is 
considered a symptom of the underlying condition. The word “pain” originates from 
the Latin “poena” which means a fine, or penalty (Visser and Davies, 2009). 
2.4.2 Nociceptor 
Nociceptor is a pain receptor and it is able to detect noxious stimuli e.g. thermal, 
mechanical and chemical stimuli (Woolf and Ma, 2007). The nociceptors will 
transduce the stimuli into electrical signal before transmitted to the central nervous 
system. They are formed by the free nerve endings of primary afferent Aδ and C 
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fibres (Reddi et al., 2013). The nociceptors are numerous in the periphery (skin) and 
it is sparse in the visceral organs. 
2.4.3 Pain pathway 
Pain information in the form of nerve impulses is carried from nociceptors to the 
spinal cord and delivered to the brain. Pain can be modified or modulated in the 
dorsal horn at the level of spinal cord. 
There are two major pathways that transmit nociceptive signals to the brain. The first 
pathway is spinothalamic tract, which transmits sensory information from the 
periphery to the central nervous system. The first afferent neurons transfer 
information from peripheral sensory receptors to spinal cord. The neurons will 
synapse with the second order neuron at the level of spinal cord. The second order 
neurons will cross to the opposite site of the spinal cord and ascend to the brainstem, 
medulla, hypothalamus, and limbic systems before projecting to the thalamus. These 
brain structures have an essential role in localisation and intensity of pain, emotional 
pain, autonomic and affective responses to pain (Almeida et al., 2004). The second 
order neurons will synapse with the third order neurons in the thalamus. These 
neurons will project and terminate in the somatosensory cortex. 
Meanwhile, the second pathway of transmitting the nociceptive information is 
spinoreticular tract. The fibres interpret and travel up from contralateral cord to the 
reticular formation in the brainstem, before reaching to the thalamus, hypothalamus 
and further projections to the cerebral cortex. The reticular formation comprises of 
nerve cells in the brainstem that involved in integrating ascending and descending 
information between spinal cord and cerebral cortex. The areas of the reticular 
formation are involved with the affective or mood response to pain and also activate 
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brain stem areas responsible for the suppression of pain response by the descending 
pain pathway (Almeida et al., 2004; Swenson, 2006). 
2.4.4 Neurotransmitters in pain transmission 
Neurotransmitters are the chemical messengers that transmit the signals throughout 
the synapse from one neuron to another. They stimulate the muscle fibres at the end 
of an axon of motor neurons. There are two types of neurotransmitters that involve in 
the pain transmission namely excitatory neurotransmitters and inhibitory 
neurotransmitters. These neurotransmitters come from different chemical classes 
such as endogenous opioid and non-opioid peptides, amines and amino acids. The 
excitatory neurotransmitters stimulate the transmission of pain impulses throughout 
the synaptic cleft to the nociceptive dorsal horn neurons, whereas the release of 
inhibitory neurotransmitters will inhibit the pain transmission process. Various types 
of chemical neurotransmitters involved in pain transmission are listed in Table 2.1. 
2.4.5 Modulation of pain 
There are two types of modulation at the level of the spinal cord; segmental 
modulation and descending regulation. Segmental modulation of nociceptive afferent 
impulses is by postsynaptic inhibitory mechanisms that act on second order neurons 
and involve inhibitory neurotransmitters such as gamma-aminobutyric acid (GABA) 
or glycine (Game and Lodge, 1975; Duggan, 1982). It has been suggested that the 
circuits in the central nervous system can modulate pain information. The gate 
control theory and the descending inhibition are one of such a circuit.  
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Table 2.1 Chemical neurotransmitters and neuromodulators involved in pain 
transmission (Steeds, 2009). 
 
Class Neurotransmitters 
Excitatory Inhibitory 
Amines  Adenosine 
triphosphate (ATP) 
 
 Noradrenaline 
 5-hydroxytryptamine 
or serotonin (5-HT) 
Endogenous opioid 
peptides 
 None 
 Enkephalins 
 B-Endorphin 
Non-opioid peptides  Substances P 
 Calcitonin gene-
related peptide  
 Galanin 
 Cholecystokinin 
Amino acids  Glutamate 
 GABA 
 glycine 
Others  Nitrous oxide 
 Bradykinin 
 Cannabinoids 
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2.4.5 (a) Gate control theory 
In 1965, Melzack and Wall has suggested the gate control theory to describe an 
inhibitory pain modulation process at the spinal cord level by suggesting the 
contribution of large nerve fibres in inhibiting the transmission of nociceptive 
signals. Small nerve fibres transmit nociceptive signals and large nerve fibres 
transmit non-nociceptive signals. Both of the fibres synapse on projection neurons 
which will carry the information to the brain. With pain stimulation, small nerve 
fibres are activated and they will block the inhibitory interneurons. The gate will 
open and lead to the transmission of pain impulse to the brain. 
With stimulation of large fibres (Aβ fibres), the inhibitory interneurons are activated 
and lead to closing of the gate. When small nerve fibres (C-fibres) are stimulated 
without stimulation of the large fibres, the inhibitory interneurons are not activated, 
so there is opening of the gate that lead to pain transmission to the higher centre. On 
the other hand, if there is simultaneous stimulation of small and large nerve fibres, 
the pain transmission will be blocked because the large fibres will activate the 
inhibitory interneurons that lead to gate closure (Larbig, 1991). 
2.4.5 (b) Descending Inhibition 
The periaqueductal grey (PAG) in the midbrain is involved in descending inhibitory 
modulation. It contains high concentrations of opioid receptors and endogenous 
opioids. Descending pathways project to the dorsal horn and inhibit pain 
transmission. These pathways are monoaminergic, utilising noradrenaline and 
serotonin as neurotransmitters. 
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The PAG receives input from the hypothalamus, amygdala and the cortex. Its 
neurons project to the medulla. The fibres then descend downwards to activate the 
inhibitory interneurons in the spinal cord, which can inhibit the incoming pain 
transmission. Another finding also indicated that PAG excited neurons in the locus 
ceruleus (cluster of neurons on the pons) which then excite the noradrenergic efferent 
in the dorsolateral tegmental nucleus (Samuels and Szabadi, 2008) which then inhibit 
pain signals. 
2.4.6 Sensitisation of pain 
Sensitisation occurs when the excitability of neurons increases (hypersensitivity) and 
they become more responsive to stimuli or sensory inputs. Typically, a strong 
stimulus is required to stimulate the nociceptors. However, following sensitisation, 
they are stimulated by innocuous stimuli and their activation will produce 
pathological pain and is a reflection of neuroplasticity (Scholz and Woolf, 2002). 
The two types of pathological pain that occur due to neuronal sensitisation are 
hyperalgesia and allodynia. Hyperalgesia is a condition when there is an increase in 
neuron responses to noxious stimuli. Meanwhile, allodynia occurs when there is an 
increase in pain response to normal innocuous stimuli. Both of these conditions are 
contributed by two main mechanisms which are peripheral sensitisation and central 
sensitisation (Ji et al., 2003). 
2.4.6 (a) Peripheral sensitisation 
The IASP describes peripheral sensitisation as “increased responsiveness and 
reduced threshold of nociceptive neurons in the periphery to the stimulation of their 
receptive field”. In general, peripheral sensitisation is and increased sensitivity to 
afferent nerve stimuli. This occurs following the cell injury and neuropeptides is 
  
24 
 
produced by the nociceptors. Hence, it stimulates high threshold nociceptors in 
response to non-noxious stimuli which is primary hyperalgesia or primary allodynia. 
For example, a gentle hit to the skin prior the injury is not painful but after injury is 
interpreted as pain (Bolay and Moskowitz, 2002).  
This can occur as a result of inflammation. The release of chemical mediators of 
inflammation e.g. histamine, bradykinin, acids and serotonin may either be 
stimulated, depolarised or sensitised (bringing the membrane potential closer to 
the depolarisation threshold). This affects the threshold known as peripheral 
sensitisation. It occurs when the chemical mediators stimulate the receptors on 
the nociceptive terminals and influences the protein enzyme cascade which then 
up-regulates the ion channels and sodium specific nociceptive channels. 
Subsequently, it becomes more sensitive to the chemical mediators and leads to 
an influx of ions which in turns stimulate the action potentials and producing 
pain (Bolay and Moskowitz, 2002; Staud and Smitherman, 2002). 
2.4.6 (b) Central sensitisation 
The IASP describes central sensitisation as “increased responsiveness of nociceptive 
neurons in the central nervous system to their normal or subthreshold afferent input” 
(Loeser and Treede, 2008). In general, central sensitisation refer to the conditions in 
which there is an increase in the function of neurons involved in nociception in the 
spinal cord and the brain (Smart et al., 2010) resulting in hypersensitivity to stimuli 
(Latremoliere and Woolf, 2009), responsiveness to non-noxious stimuli (Loeser and 
Treede, 2008) and enhanced pain response induced by stimuli outside the area of 
injury. 
